T1	Treatment 96 170	captopril, atenolol and pravastatin combined with life style intervention.
T2	Treatment 247 485	angiotensin converting enzyme inhibitor (captopril), and a beta-receptor blocking agent (atenolol), given alone or in combination with a cholesterol reducing drug, the beta-hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin
T3	Treatment 503 551	were also encouraged to improve their lifestyle.
T4	Treatment 611 640	Lifestyle intervention alone.
T5	Treatment 645 714	Continued lifestyle intervention combined with captopril or atenolol.
T6	Treatment 720 836	Continued lifestyle intervention combined with the same drugs as in phase II and in addition pravastatin or placebo.
T7	Treatment 1206 1228	captopril and atenolol
T8	Treatment 1280 1292	pravastatin.
T9	Treatment 1307 1318	pravastatin
T10	Treatment 1365 1387	captopril or atenolol.
T11	Treatment 1472 1482	diuretics.
T12	Treatment 1494 1505	Pravastatin
T13	Treatment 1538 1559	captopril or atenolol
